Taiwan Biomaterial Co., Ltd. (TPEX:6649)
Taiwan · Delayed Price · Currency is TWD 38.40
+0.10 (0.26%)
May 29, 2026, 1:18 PM CST
Taiwan Biomaterial Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 26.02 | 58.93 | -1.73 | -10.13 | 33.76 | -47.44 |
Depreciation & Amortization | 15.42 | 15.7 | 16.79 | 16.96 | 15.98 | 10.21 |
Other Amortization | 0.93 | 0.93 | 0.9 | 0.91 | 0.92 | 0.85 |
Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.04 |
Stock-Based Compensation | - | - | - | - | - | 0.26 |
Other Operating Activities | -0.31 | -0.44 | -1 | 0.82 | -0.25 | 0.01 |
Change in Accounts Receivable | -13.14 | -24.14 | 2.47 | 1.65 | -13.64 | 3.53 |
Change in Inventory | -43.98 | -18.75 | 7.84 | -30.64 | -7.82 | -4.06 |
Change in Accounts Payable | 2.48 | 15.55 | -3.55 | 4.63 | 2.79 | 0.02 |
Change in Unearned Revenue | -1.5 | 0.29 | 0.47 | - | - | -0.15 |
Change in Other Net Operating Assets | 31.88 | 0.7 | -3.75 | 5.65 | -2.44 | 10.44 |
Operating Cash Flow | 17.81 | 48.77 | 18.43 | -10.16 | 29.31 | -26.29 |
Operating Cash Flow Growth | -70.89% | 164.68% | - | - | - | - |
Capital Expenditures | -2.65 | -1.44 | -3.69 | -2.57 | -35.67 | -28.01 |
Sale of Property, Plant & Equipment | - | - | - | - | 0.07 | - |
Sale (Purchase) of Intangibles | -1.75 | -1.7 | -0.96 | -0.64 | -1.81 | -1.69 |
Investment in Securities | 19.96 | 9.96 | 24.96 | 16.97 | -88.51 | 76.89 |
Other Investing Activities | -7.4 | 0.13 | 0.21 | 0.23 | 5.37 | 1.14 |
Investing Cash Flow | 8.17 | 6.95 | 20.53 | 13.98 | -120.55 | 48.34 |
Long-Term Debt Repaid | - | -4.4 | -5.29 | -6.89 | -7.03 | -2.24 |
Net Debt Issued (Repaid) | -4.42 | -4.4 | -5.29 | -6.89 | -7.03 | -2.24 |
Issuance of Common Stock | - | - | - | - | 189.78 | 1.03 |
Common Dividends Paid | -42 | - | - | -8.4 | - | - |
Other Financing Activities | 1.74 | 1.74 | - | - | - | - |
Financing Cash Flow | -44.68 | -2.66 | -5.29 | -15.29 | 182.75 | -1.21 |
Net Cash Flow | -18.7 | 53.06 | 33.67 | -11.47 | 91.5 | 20.84 |
Free Cash Flow | 15.16 | 47.33 | 14.74 | -12.74 | -6.36 | -54.3 |
Free Cash Flow Growth | -74.09% | 221.06% | - | - | - | - |
Free Cash Flow Margin | 8.46% | 21.47% | 15.26% | -17.49% | -5.00% | -130.31% |
Free Cash Flow Per Share | 0.36 | 1.13 | 0.35 | -0.30 | -0.16 | -1.65 |
Cash Interest Paid | 0.74 | 0.74 | 0.8 | 0.87 | 0.97 | 1.03 |
Cash Income Tax Paid | 0.37 | 0.37 | 0.21 | 0.25 | 0.09 | - |
Levered Free Cash Flow | 7.75 | 25.66 | 8.13 | -12.64 | -60.21 | -17.57 |
Unlevered Free Cash Flow | 8.2 | 26.12 | 8.63 | -12.09 | -59.6 | -16.93 |
Change in Working Capital | -24.26 | -26.35 | 3.48 | -18.71 | -21.1 | 9.78 |